Clinical Trials Browser

Phase 2 × Unknown × avelumab × Clear all

NCT05289856 2024-03-07

Cabozantinib in Combination With Avelumab in Patients Refractory to Standard Chemotherapy With Advanced Neuroendocrine Neoplasias G3 (NEN G3)

Phase 2 Unknown

Neoplasms

NCT05291156 2024-02-01

CAVE-2 GOIM Study: a Clinical Study of the Combination of Avelumab Plus Cetuximab as Rechallenge Strategy

Phase 2 Unknown

Gastrointestinal

Colorectal Neoplasms

NCT03617666 2023-12-12

AVENuE

Phase 2 Unknown

Hodgkin Disease

NCT03503786 2023-11-13

MITO END-3

Phase 2 Unknown

Endometrial Neoplasms

NCT03568097 2023-06-02

PAVE

Phase 2 Unknown

Small Cell Lung Carcinoma

NCT03774901 2023-04-21

PULSE

Phase 2 Unknown

Penile Neoplasms

NCT05429866 2023-03-08

Immunological Variables Associated to ICI Toxicity in Cancer Patients

Phase 2 Unknown

BreastDermatologicGastrointestinalGenitourinaryHead & NeckOther solid neoplasmThoracic

Mesothelioma, Malignant, Urinary Bladder Neoplasms, Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Gastrointestinal Neoplasms, Head and Neck Neoplasms, Carcinoma, Hepatocellular, Melanoma, Carcinoma, Merkel Cell, Small Cell Lung Carcinoma

NCT04571632 2022-09-14

Luscid

Phase 2 Unknown

Carcinoma, Non-Small-Cell Lung

NCT03491345 2022-08-09

K-Basket, Avelumab, Biomarker-driven, Advanced Solid Tumor

Phase 2 Unknown

Other solid neoplasm

PD-L1 Positive Mutation Tumor

NCT03439501 2021-09-24

Avelumab in Relapsed or Refractory Extranodal Natural Killer/T-cell Lymphoma[AVENT STUDY]

Phase 2 Unknown

Lymphoma, Extranodal NK-T-Cell

NCT03800953 2021-09-08

The Ave-CRT Study for Newly Diagnosed Metastatic Esophageal Squamous Cell Carcinoma

Phase 2 Unknown

Gastrointestinal

Esophageal Squamous Cell Carcinoma, Esophageal Neoplasms

NCT04698213 2021-01-06

TIDE-A

Phase 2 Unknown

Carcinoma, Neoplasm Metastasis

NCT03608046 2020-10-22

AVETUXIRI

Phase 2 Unknown

Gastrointestinal

Colonic Neoplasms

NCT03150706 2020-04-03

Avelumab for MSI-H or POLE Mutated Metastatic Colorectal Cancer

Phase 2 Unknown

Gastrointestinal

Turcot syndrome, Colorectal Neoplasms

NCT03944252 2019-07-26

CARACAS

Phase 2 Unknown

Gastrointestinal

Anus Neoplasms

NCT03966118 2019-06-03

AIO-STO-0218

Phase 2 Unknown

Gastrointestinal

Stomach Neoplasms

NCT03950362 2019-05-16

PREVERT

Phase 2 Unknown

Non-Muscle Invasive Bladder Neoplasms

NCT03812796 2019-02-05

EMERGE

Phase 2 Unknown

Gastrointestinal

Gastrointestinal Neoplasms, Neoplasms

NCT03512834 2018-07-11

ASAP

Phase 2 Unknown

Hemangiosarcoma

NCT03341845 2018-05-21

Neoadjuvant AXITINIB and AVELUMAB for Patients With Localized Clear-cell RCC

Phase 2 Unknown

Carcinoma, Renal Cell